Biodesix (BDSX) Equity Average (2020 - 2025)
Historic Equity Average for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to -$292000.0.
- Biodesix's Equity Average fell 10091.08% to -$292000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$292000.0, marking a year-over-year decrease of 10091.08%. This contributed to the annual value of $12.7 million for FY2024, which is 107.2% up from last year.
- Per Biodesix's latest filing, its Equity Average stood at -$292000.0 for Q3 2025, which was down 10091.08% from $6.1 million recorded in Q2 2025.
- Biodesix's 5-year Equity Average high stood at $38.8 million for Q1 2021, and its period low was -$4.2 million during Q3 2023.
- In the last 5 years, Biodesix's Equity Average had a median value of $12.6 million in 2023 and averaged $12.8 million.
- Per our database at Business Quant, Biodesix's Equity Average crashed by 27699.24% in 2023 and then soared by 356377.44% in 2025.
- Quarter analysis of 5 years shows Biodesix's Equity Average stood at $17.9 million in 2021, then plummeted by 50.49% to $8.9 million in 2022, then plummeted by 82.3% to $1.6 million in 2023, then soared by 1454.98% to $24.4 million in 2024, then plummeted by 101.2% to -$292000.0 in 2025.
- Its Equity Average was -$292000.0 in Q3 2025, compared to $6.1 million in Q2 2025 and $16.0 million in Q1 2025.